[
  {
    "ts": "2025-10-14T12:00:00+00:00",
    "headline": "Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call",
    "summary": "WILMINGTON, Mass., October 14, 2025--Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-schedules-third-120000555.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "917386a5-00ac-3d63-bcb3-174a73a2ba31",
      "content": {
        "id": "917386a5-00ac-3d63-bcb3-174a73a2ba31",
        "contentType": "STORY",
        "title": "Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call",
        "description": "",
        "summary": "WILMINGTON, Mass., October 14, 2025--Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call",
        "pubDate": "2025-10-14T12:00:00Z",
        "displayTime": "2025-10-14T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/d7ceea22db43f6b1b513712f1474a4db",
          "originalWidth": 1245,
          "originalHeight": 326,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LICZgStzQHJ9TMytw2dc4w--~B/aD0zMjY7dz0xMjQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/d7ceea22db43f6b1b513712f1474a4db.cf.webp",
              "width": 1245,
              "height": 326,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ERovfaUsrX2ArQGefnQG1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/d7ceea22db43f6b1b513712f1474a4db.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-schedules-third-120000555.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-schedules-third-120000555.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-14T04:02:32+00:00",
    "headline": "3 Reasons to Avoid CRL and 1 Stock to Buy Instead",
    "summary": "The past six months have been a windfall for Charles River Laboratories’s shareholders. The company’s stock price has jumped 60.1%, hitting $170.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
    "url": "https://finance.yahoo.com/news/3-reasons-avoid-crl-1-040232540.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "1cab6cb7-d452-3cd8-ad18-bad95a58e298",
      "content": {
        "id": "1cab6cb7-d452-3cd8-ad18-bad95a58e298",
        "contentType": "STORY",
        "title": "3 Reasons to Avoid CRL and 1 Stock to Buy Instead",
        "description": "",
        "summary": "The past six months have been a windfall for Charles River Laboratories’s shareholders. The company’s stock price has jumped 60.1%, hitting $170.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
        "pubDate": "2025-10-14T04:02:32Z",
        "displayTime": "2025-10-14T04:02:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CRL Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PLZRbui545u2bOcqTkunEw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YlRDliezLyxJ3r.biO59fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-avoid-crl-1-040232540.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-avoid-crl-1-040232540.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]